Why the study?
Does therapy directed at improving orthostasis prevent recurrent micturition syncope or sudden death in patients with micturition syncope?
Does therapy directed at improving orthostasis prevent recurrent micturition syncope or sudden death in patients with micturition syncope?
Micturition syncope occurs not only in young healthy men but also in older patients, predominantly women with multiple comorbidities and orthostatic hypotension, who have a benign course when treated for orthostasis.
Answers are grounded in this paper and cite their sources.
Supports orthostasis-directed care in older comorbid patients; leaves open need for randomized confirmation of benefit.
We prospectively studied 33 patients with micturition syncope. Of these, eight were young (mean age, 25 years), healthy individuals whose diagnostic evaluation gave normal findings. The remaining 25 patients were older (mean age, 60 years), and 16 were women. This group had an average of 3.8 acute and chronic illnesses per patient, and was taking 3.5 medications per patient. Physical examination disclosed orthostatic hypotension in 22 of these 25 patients. Therapy was directed at improving orthostasis. Over a mean of 15.3 months, no recurrent micturition syncope or sudden death occurred in the entire group. We conclude that there are two groups of patients with micturition syncope. A group consisting of young healthy men has been well described previously. Our larger group, however, consisted of older patients, more often women with multiple illnesses and the majority having orthostatic hypotension.
No takes yet. Share an insight, caveat, or question.
Wishwa N. Kapoor (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: